VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 300 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2017. The put-call ratio across all filers is 2.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $1,648,000 | +163.7% | 114,975 | +218.0% | 0.01% | +200.0% |
Q2 2017 | $625,000 | +86.0% | 36,156 | +19.2% | 0.00% | +100.0% |
Q1 2017 | $336,000 | -59.3% | 30,330 | -46.6% | 0.00% | -66.7% |
Q4 2016 | $825,000 | -24.6% | 56,822 | +27.4% | 0.00% | -25.0% |
Q3 2016 | $1,094,000 | -82.5% | 44,586 | -85.6% | 0.00% | -83.3% |
Q2 2016 | $6,238,000 | -38.3% | 309,677 | -19.5% | 0.02% | -50.0% |
Q1 2016 | $10,112,000 | -77.2% | 384,509 | -12.1% | 0.05% | -76.9% |
Q4 2015 | $44,447,000 | -53.9% | 437,247 | -19.2% | 0.21% | -56.6% |
Q3 2015 | $96,488,000 | -22.2% | 540,911 | -3.1% | 0.48% | -17.7% |
Q2 2015 | $123,963,000 | +57.3% | 558,016 | +40.6% | 0.58% | +65.8% |
Q1 2015 | $78,820,000 | -0.3% | 396,845 | -27.2% | 0.35% | +3.8% |
Q4 2014 | $79,077,000 | +76.9% | 544,905 | +59.9% | 0.34% | +77.0% |
Q3 2014 | $44,706,000 | +30.5% | 340,746 | +25.5% | 0.19% | +31.7% |
Q2 2014 | $34,252,000 | -6.2% | 271,577 | -2.0% | 0.14% | -1.4% |
Q1 2014 | $36,527,000 | -0.6% | 277,070 | -11.5% | 0.15% | -3.3% |
Q4 2013 | $36,762,000 | +44.3% | 313,131 | +28.2% | 0.15% | +35.7% |
Q3 2013 | $25,474,000 | – | 244,167 | +19.3% | 0.11% | – |
Q2 2013 | $0 | – | 204,625 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |